10.1631/jzus.B10e1012," /> 10.1631/jzus.B10e1012,"/> 10.1631/jzus.B10e1012,"/>
Please wait a minute...
ZJUS-B
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2010, Vol. 11 Issue (8): 631-633    DOI: 10.1631/jzus.B1001012
Viewpoints     
Current status and development of percutaneous coronary intervention in China
Yong Huo
Department of Cardiology and Heart Center, Peking University First Hospital, Beijing 100034, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Dr. Gruntzig et al. (1979) successfully completed the world鈥檚 first percutaneous coronary intervention (PCI), a percutaneous transluminal coronary angioplasty (PTCA), in 1977. The first reported PTCA in China was in 1984. With the development of PCI techniques, while more and more patients have benefited, there are ongoing challenges as well.

Key words： Percutaneous coronary intervention (PCI)      Coronary heart disease      10.1631/jzus.B10e1012')" href="#">Quality control

An erratum to this article can be found at doi:10.1631/jzus.B10e1012     
Received: 25 June 2010      Published: 02 August 2010
CLC:  R54  
Service
E-mail this article 10.1631/jzus.B10e1012”. Please open it by linking:http://www.zjujournals.com/xueshu/zjus-b/EN/abstract/abstract14701.shtml" name="neirong"> 10.1631/jzus.B10e1012">
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Yong Huo
Cite this article:

Yong Huo. Current status and development of percutaneous coronary intervention in China. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(8): 631-633.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1001012     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2010/V11/I8/631

[1] Hui-yong Peng, Chang-feng Man, Juan Xu, Yu Fan. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 78-86.
[2] Jian-ping Li, Mohetaboer Momin, Yong Huo, Chun-yan Wang, Yan Zhang, Yan-jun Gong, Zhao-ping Liu, Xin-gang Wang, Bo Zheng. Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(8): 638-644.
[3] Yan-jun Gong, Tao Hong, Jie Jiang, Rong-hui Yu, Yan Zhang, Zhao-ping Liu, Yong Huo. Influence of education and working background on physicians’ knowledge of secondary prevention guidelines for coronary heart disease: results from a survey in China[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(3): 231-238.
[4] Yan Zhang, Yong Huo. Early reperfusion strategy for acute myocardial infarction: a need for clinical implementation[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(8): 629-632.
[5] Chun-na Jin, Hong Ma, Yan Lin, Jian-an Wang, Mei-xiang Xiang. Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(8): 660-667.
[6] Xin Du, Jun-ping Kang, Jia-hui Wu, Qiang Lv, Chao-shu Tang, Chang-sheng Ma. Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(8): 548-552.
[7] ZHOU Bin-quan, TAHK Seung-Jea. Effect of a distal protection device on epicardial blood flow and myocardial perfusion in primary percutaneous coronary intervention[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(8): 575-579.